Betty Wang, MD

From a practical standpoint, integrating ctDNA into clinical practice poses challenges.

Betty Wang, MD, said she envisions ctDNA integrating into existing surveillance protocols for patients with high-risk NMIBC.

Wang and Bukavina outline several cases of ctDNA's utility in the space.

A notable finding was that 35% of these NMIBC patients exhibited ctDNA positivity.

Betty Wang, MD, provides insight on 3 presentations that she believes “may be game changing” in urology.